Previous Article | Next Article ![]()
Journal of Virology, December 2000, p. 11782-11791, Vol. 74, No. 24
The Marjorie B. Kovler Viral Oncology
Laboratories, The University of Chicago, Chicago, Illinois
60637,1 and Section of Microbiology and
Virology, Department of Experimental Pathology, University of Bologna,
Bologna, Italy2
Received 14 July 2000/Accepted 14 September 2000
We have made two stocks of a herpes simplex virus 1 mutant lacking
intact US5 and US6 open reading frames encoding
glycoproteins J (gJ) and D (gD), respectively. The stock designated
gD In this report we show that herpes
simplex virus 1 (HSV-1) mutants lacking the gene encoding glycoprotein
D (gD) and which attach to cell surfaces but cannot initiate productive
infection, or initiate an infection with production of gD-deficient
progeny, nevertheless induced programmed cell death. The circumstances which led us to initiate these studies were as follows.
This and other laboratories have extensively documented evidence that
wild-type HSV-1 blocks programmed cell death induced by exogenous
agents and that mutants in early functions induce programmed cell death
(2, 3, 17, 18, 22-24, 39). The studies reported from this
laboratory began with the observation that a mutant lacking the gene
encoding infected cell protein 4 (ICP4) The initiation of infection prior to the release of viral DNA involves
attachment of the virion to the cell surface mediated by gC, and
possibly gB (20, 35, 38), fusion of the envelope with the
plasma membrane mediated minimally by gD but with the involvement of
gB, gH, and gL (8, 15, 25, 33); see also references (9) and
(35), release of tegument proteins and capsid-tegument proteins
from the virion into the cytoplasm, and transport of a capsid-tegument
protein to the nuclear pore and of selected tegument proteins (e.g.,
VP16 or We report that both gD Cells.
SK-N-SH, HEp-2 and Vero cells were obtained from
American Type Culture Collection (Manassas, Va.) and maintained in
Dulbecco's modification of Eagle minimal essential medium (DMEM)
containing 10% fetal bovine serum. Insect cell line Sf9
(Spodoptera frugiperda) was obtained from PharMingen (San
Diego, Calif.). Unless indicated, cultures were seeded less than
20 h prior to infection and assayed at 60 to 70% confluence.
VD60, a cell line carrying the entire BamHI J fragment
(25), was a kind gift from D. Johnson. R6 cells were derived
from rabbit skin cells in the course of this study. Plasmid pEA102
containing the HSV-1 gD coding sequence under the UL26.5
promoter was constructed as follows. The gD coding sequence was
amplified by PCR with primers CTCTTTTGTCTCGAGCGTTCCGGTATGGGG (forward) and GTCAGGTCTGCGGGCTCGAGATGGGACCTT (reverse)
to yield a fragment that includes the entire gD coding sequence from 14 bp upstream of the start codon to 32 bp downstream of the stop codon.
The purified fragment, excised with XhoI, was filled in and
cloned into the HindIII site of pEA101. pEAl01 was
derived from pcDNA 3.1( Viruses.
HSV-1(F) is the prototype HSV-1 strain used in
these laboratories (14). The ICP4 deletion mutant
d120 was described elsewhere (13). In the FgD Baculovirus transfer vectors.
pAc-CMV, kindly provided by
M.-T. Sciortino, was derived from the pAcSG2 baculovirus transfer
vector (PharMingen) by cloning an XhoI-EcoRI
fragment containing the human CMV (HCMV) IE1 promoter/enhancer sequences (provided by L. Hennighausen) in the
XhoI-BamHI site of pAcSG2. An
EcoRI-BglII fragment encoding gD was amplified by PCR from pEA99 with primers CGGAA-TTCAT-GGGGG-GGGCT-GCCGC-CAG and GAAGA-TCTCT-AGTAA-AACAA-GGGCT-GGTG-CG. The
amplified PCR fragment was inserted into the
EcoRI-BglII sites of the pAc-CMV polylinker, resulting in the pAc-gD transfer vector. The pAc-gJ transfer vector was
constructed by the same strategy as pAc-gD. The primers used for PCR
amplification were CGGAATTCATGTCTCTGCGCGCAGTCTGGCATC and GAAGATCTTTTAATATGCTGTTG. Plasmid pRB5252 (29) was
digested with EcoRI and BglII. The 1.2-kb
fragment containing the Generation of recombinant baculovirus.
Bac-gD, Bac-gJ,
Bac- Exposure of mammalian cells to recombinant baculovirus.
Subconfluent cultures of SK-N-SH cells in 25-cm2 flasks
were exposed to 10 to 100 PFU of recombinant baculovirus per cell as stated in Results and incubated at 37°C for 1 h. Then culture medium was then replaced with fresh DMEM containing 10% fetal bovine
serum and 2.5 mM sodium butyrate or at concentrations stated in Results
and incubated at 37°C for stated time intervals.
Antibodies.
Monoclonal antibodies against gD (clone H170),
ICP0 (clone H1083), and gB (clone 1817) were purchased from the Goodwin
Cancer Research Institute, Plantation, Fl. The monoclonal antibody to gI (26), the polyclonal antibody R77 to ICP22
(1), and polyclonal antibodies to UL38 and gJ
were described elsewhere (11, 37).
Immunblot assays.
Protein concentrations of whole-cell
lysates was determined with the Bio-Rad protein assay (Bio-Rad
Laboratories, Hercules, Calif.). Infected or uninfected cell lysates
(50 µg of protein per lane) were electrophoretically separated in
12% denaturing polyacrylamide gels. Proteins were then electrically
transferred to a nitrocellulose sheet (Bio-Rad), blocked for 2 h
in 5% milk in PBS at room temperature, and then reacted with the
primary antibody. The protein bands were visualized by means of an
enhanced chemiluminescence detection system (Pierce, Rockford, Ill.)
according to the manufacturer's instructions.
Double infection.
Replicate subconfluent cultures of SK-N-SH
cells were exposed to 10 PFU of recombinant baculovirus or 100 PFU of
Bac-XylE per cell and incubated at 37°C for 2 h. The cells were
exposed to either 100 PFU equivalents of gD Induction of apoptosis by TNF- Immunofluorescence.
SK-N-SH cells (5 × 104) were seeded onto four-well glass slides and either
exposed to recombinant baculoviruses or doubly infected as described
above. Cells were fixed in ice-cold methanol for 20 min at DNA fragmentation assay.
Infected or uninfected cells were
collected, washed in PBS, lysed in a solution containing 10 mM Tris-HCl
(pH 8.0), 10 mM EDTA, and 0.5% Triton X-100, digested with RNase A
(0.1 mg/ml) at 37°C for 1 h, and centrifuged at 12,000 rpm for
25 min in an Eppendorf microcentrifuge to pellet chromosomal DNA. The
supernatant fluids were digested with proteinase K (1 mg/ml) at 50°C
for 2 h in the presence of 1% sodium dodecyl sulfate, extracted
with phenol and chloroform, precipitated in cold ethanol, and subjected to electrophoresis on 1.5% agarose gels containing 0.5 mg of ethidium bromide per ml. Oligonucleosomal DNA fragments were visualized by UV
light transillumination. Photographs were taken with the aid of Eagle
Eye II (Stratagene).
Experimental design.
To simplify presentation of the data, we
have adopted the following specific nomenclature for the viruses used
in this study. Wild-type viruses are termed gD+/+ to
signify that they contain both the US6 gene encoding gD and gD contained in the envelope; gD Characteristics of the gD
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Glycoprotein D or J Delivered in trans
Blocks Apoptosis in SK-N-SH Cells Induced by a Herpes Simplex Virus 1 Mutant Lacking Intact Genes Expressing Both Glycoproteins
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/+, made in cells carrying US6 and
expressing gD, was capable of productively infecting cells, whereas the
stock designated gD
/
, made in cells lacking viral DNA
sequences, was known to attach but not initiate infection. We report
the following. (i) Both stocks of virus induced apoptosis in SK-N-SH
cells. Thus, annexin V binding to cell surfaces was detected as early
as 8 h after infection. (ii) US5 or US6
cloned into the baculovirus under the human cytomegalovirus
immediate-early promoter was expressed in SK-N-SH cells and blocked
apoptosis in cells infected with either gD
/+ or
gD
/
virus, whereas glycoprotein B, infected cell
protein 22, or the wild-type baculovirus did not block apoptosis. (iii)
In SK-N-SH cells, internalized, partially degraded virus particles were
detected at 30 min after exposure to gD
/
virus but not
at later intervals. (iv) Concurrent infection of cells with
baculoviruses did not alter the failure of gD
/
virus
from expressing its genes or, conversely, the expression of viral genes
by gD
/+ virus. These results underscore the capacity of
herpes simplex virus to initiate the apoptotic cascade in the absence
of de novo protein synthesis and indicate that both gD and gJ
independently, and most likely at different stages in the reproductive
cycle, play a key role in blocking the apoptotic cascade leading to
cell death.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
the major regulatory
protein
induced apoptosis in a variety of cell lines, in both caspase
3-dependent and -independent manners (16-18, 23, 24). To
test the possibility that apoptosis can be induced by a factor
introduced into the cells during viral entry, we analyzed cells
infected with a mutant, HSV-(HFEM)tsB7, that blocks release
of viral DNA from capsids at the nonpermissive temperature
(4). Those studies showed that at the nonpermissive temperature tsB7 induced apoptosis in a cell-type-dependent
manner (16). These observations led to two conclusions.
First, HSV induced, but also blocked, programmed cell death at multiple
steps in the course of the viral replicative cycle. Second, at least one signal for induction of the apoptotic cascade could be expressed in
the absence of de novo viral gene expression.
TIF) to the nucleus (4, 5). In an attempt to sort
out which of the components of the nucleus are responsible for the
induction of the apoptotic cascade, we decided to start with the
initial steps in the attachment and entry of the virus into the
infected cell. Studies on HSV entry indicate that in the absence of gD
in both the genome and the envelope, the virus attaches but does not
penetrate. To test the role of these initial events in the induction of
apoptosis, we derived two stocks of viruses. The first, designated
gD
/+, was produced by growing a virus lacking the gD gene
in cells expressing gD (25). Because this virus contained gD
in its envelope, it could enter and produce infectious progeny in both
gD-expressing and -nonexpressing cell lines. In the latter, however,
the progeny virus remained sequestered in the infected cell. The second
stock was derived by passage of gD
/+ virus in cells that
did not carry the HSV-1 gene encoding gD. In this instance the virus,
designated gD
/
, was recovered from the infected cells.
This population of mutant viruses has been shown to attach to cells,
but expression of viral genes does not ensue.
/
and gD
/+ viruses
induce programmed cell death in human SK-N-SH cells. In cells carrying
the BamHI J fragment of HSV-1 DNA, the gD
/+
viruses recombined with the resident HSV-1 DNA, and several wild-type rescuant were isolated. Analyses of the genes in the immediate environment of US6 encoding gD indicate that
gD
/+ viruses lacked in addition to gD a wild-type
US5 encoding gJ (25). We report that both gD and
gJ delivered in trans block the apoptosis induced by
gD
/+ and gD
/
viruses whereas gB, an
unrelated gene, or the wild-type baculovirus itself did not. Finally,
at multiplicities of infection used in this study, we noted that
gD
/
viruses were taken up by vesicles likely to be of
endocytic origin and were degraded within a short interval after
exposure of cells to the virus.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) by replacement of the cytomegalovirus (CMV) promoter (excised as a 687-bp NruI-NheI fragment)
with the UL26.5 promoter, excised as a 887-bp
XbaI-BstEII fragment from pRB4090, and cloned in
the XbaI-EcoRI sites of the deleted pcDNA
3.1(
). Rabbit skin cells transfected with pEA102 were selected for
neomycin G418 resistance, cloned by limiting dilution, and assayed for gD-inducible gD expression, following infection with HSV-2. The cell
line was maintained in DMEM supplemented with 5% newborn calf serum
and 400 µg of G418 per ml.
mutant, the Escherichia coli lacZ gene replaced portions of
US6 and US7 encoding gD and gI, respectively
(25). The D10 (gD
/+) stock of FgD
was
kindly provided by D. Johnson. The P6 (gD
/+) virus,
kindly provided by P. G. Spear, is a plaque isolate derived from
FgD
in which the deletion in the gI gene has been repaired. Growth
of D10 virus in VD60 yielded spontaneous rescuants resulting from
recombination between the replicating virus and the resident HSV-1 DNA.
Three of these rescuants were plaque purified and tested as described
in Results. Virions carrying gD on their envelope provided in
trans by growth in complementing cell lines were designated gD
/+. All of stocks of gD
/+ virus used in
this study were derived in R6 cells, and titers were determined in
these cells. Virions lacking gD in both their genomes and their
envelopes were designated gD
/
. The stocks of
gD
/
and of HSV-1(F) were prepared by infecting cultures
of HEp-2 cells with 10 PFU of gD
/+ and wild-type virus,
respectively, per cell.
22 gene coding sequences (29) was
cloned into the EcoRI-BglII sites in the pAc-CMV
polylinker, generating the transfer vector pAc-22. The transfer vector
pAc-gB was constructed as follows. The complete gB coding sequence was
PCR amplified using primers
5'-GGCAC-GAGGC-CTCCC-CGTAG-TCCCG-CCATG-C (forward) and
5'-CTACG-TGTAC-TCTAG-ATTGT-GGGCA-CC (reverse) to yield a
2,792-bp fragment which included the entire gB open reading frame and 9 bp upstream of the start codon. The fragment was cloned in the
StuI-BglII sites of pAc-CMV.
22, and Bac-gB were generated using the PharMingen baculovirus
expression vector system by cotransfecting transfer vectors pAc-gD,
pAc-gJ, pAc-22, and pAc-gB, respectively, along with BaculoGold
linearized baculovirus DNA (PharMingen) into Sf9 cells according to the
manufacturer's instructions. The viruses were propagated in Sf9 cells
grown in 150-cm2 flasks in TNM-FH insect medium
(PharMingen). Virus stocks were concentrated by centrifugation at
35,000 × g for 60 min. The pelleted viruses were
resuspended in phosphate-buffered saline (PBS) supplemented with 1%
fetal bovine serum. Virus titers were determined by plaque assay on
Sf9 cells. Bac-XylE is the wild-type baculovirus provided with the PharMingen baculovirus expression vector system.
/
or 10 PFU
of gD
/+ virus per cell and incubated at 37°C for
intervals described in Results in medium containing 2.5 mM sodium butyrate.
or Fas ligand.
Cells were
exposed to either 10 ng of tumor necrosis factor alpha (TNF-
;
Calbiochem, Cambridge, Mass.) per ml of medium for 16 h or 1 µg
of anti-Fas monoclonal antibody (immunoglobulin M; Calbiochem) per ml
of medium for 12 h and then harvested.
20°C and
then blocked in PBS containing 1% bovine serum albumin at room
temperature, rinsed three times with PBS, and reacted for 24 h at
4°C with a 1:2,000 dilution of mouse monoclonal antibody against ICP0
(clone H1083) in PBS. The cells were rinsed five times in PBS, reacted
for 1 h with 1:64 dilution of a goat anti-mouse immunoglobulin G
conjugated to fluorescein isothiocyanate (FITC) (Sigma, St. Louis, Mo.)
in PBS, then rinsed five times with PBS, and mounted in 90% glycerol.
Slides were analyzed in a Zeiss confocal fluorescence microscope.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/+ denotes viruses that
lack the US6 gene but contain gD made in cells expressing a
resident US6 gene; and passage of gD
/+ in
cells lacking a resident US6 gene yielded a virus,
designated gD
/
, lacking both US6 and gD and
shown earlier to be able to attach to the cell surface but not initiate
infection (25). Initially we received from D. Johnson a cell
line expressing gD (VD60) and the FgD
(gD
/+) virus. We
also received from P. G. Spear a virus [P6 (gD
/+)]
derived from FgD
(gD
/+) but with a restored
US7 gene encoding gI. All preparations of gD
/
virus stocks were derived from P6
(gD
/+) virus. The DNA fragment contained in the VD60 cell
line exceeded the coding domain of the US6 gene. In
consequence, gD
/
stocks contained self rescuants
derived by recombination between the resident DNA and the
gD
/+ virus. At least three independent rescuants were
plaque purified and used as described below. To avoid the generation of
self-rescuants, a cell line (R6) was constructed in which the resident
HSV-1(F) DNA consisted of the US6 open reading frame fused
to the UL26.5 promoter. The R6 cell line expressed gD only
after infection with gD
/+ virus and yielded no detectable
self-rescuants. All of the gD
/+ stocks used in this study
were made in R6 cells. The gD
/
virus was generated from
these gD
/+ stocks.
/
virus.
To estimate
the relative quantities of gD contained in gD
/
preparations, HEp-2 cells were exposed to 10 PFU of gD
/+
virus made in R6 cells. Total lysates of cells harvested at 18 h
after infection was subjected to denaturing electrophoresis in a single
lane. Adjacent lanes were loaded with lysates of cells infected with
wild-type virus [HSV-1(F)] serially diluted to contain the content of
a specific number of cells. The electrophoretically separated
polypeptides prepared in duplicate were reacted with a polyclonal
antibody to the capsid protein 19C encoded by UL38 and
monoclonal antibody to gD. The results (Fig.
1) show that the quantity of gD
accumulating in the gD
/
stock was significantly less
than 100-fold lower than that contained in HSV-1(F)-infected cells,
whereas the amounts of UL38 protein accumulating in cells
infected with gD
/
stock was higher than that present in
the equivalent amount of HSV-1(F)-infected cells. We estimate on the
basis of these results that the amount of gD present in the
gD
/
stock containing a lysate from 107
cells was equivalent to that present in 1 × 104 to
2 × 104 cells.

View larger version (53K):
[in a new window]
FIG. 1.
Determination of PFU equivalents in a stock of
gD
/
mutant virus. Stocks of HSV-1(F) and
gD
/
were prepared as described in Materials and
Methods. Aliquots from these stocks corresponding to the number of cell
equivalents indicated were electrophoretically separated in 10%
denaturing polyacrylamide gels and electrically transferred onto a
nitrocellulose sheet. The samples were reacted with a
UL38-specific polyclonal antiserum and with a gD monoclonal
antibody. PFU equivalents for gD
/
stocks were estimated
from the ratios of UL38 protein. Sizes are indicated in
Mr × 1,000.
gD
/
virus induces annexin V presentation on cell
surfaces.
To determine whether both gD
/
and
gD
/+ mutant virus stocks induce apoptosis, two
experiments were done. In the first, the cells were mock infected or
infected with the d120 or gD
/
mutant. The
micrographs in Fig. 2 show that the
patterns of annexin V binding to cells infected with the
d120 mutant were similar to those observed on cells infected
with the gD
/
mutant. In the second experiment, (Fig.
2D), the cells were mock infected or infected with HSV-1(F),
gD
/
, or gD
/+, and annexin V-positive
cells were counted as a percentage of total cells. The results indicate
that annexin V bound to the cells as early as 8 h after infection
and that the fraction of cells binding annexin V was significantly
greater than that binding mock-infected or wild-type virus-infected
cells. The slight decrease in the percentage of annexin V-positive
cells at 18 h after infection may reflect the loss from the slide
surface of cells in more advanced stages of apoptosis. These results
are consistent with the hypothesis that both gD
/
and
gD
/+ viruses induce apoptosis.
|
gD
/
and gD+/+ viruses induce DNA
fragmentation in SK-N-SH cells.
In this series of experiments,
SK-N-SH cells were exposed to 10 PFU of HSV-1(F), gD
/+,
or two independently derived self-rescuants per cell and to either 10 or 100 PFU equivalents of gD
/
virus per cell. The cells
were harvested at 18 h after mock infection or exposure to virus
and processed as described in Materials and Methods. As shown in Fig.
3, low-molecular-weight DNA ladders were
seen in cells infected with d120 (positive control) and in cells infected with gD
/+ or with 100 PFU equivalents of
gD
/
, but not in mock-infected cells, cells infected
with the self-rescuants, or cells exposed to 10 PFU of
gD
/
virus. We conclude from these results the
following. (i) Consistent with the data presented in Fig. 2, both
gD
/+ and gD
/
viruses induce fragmentation
of DNA consistent with an apoptotic response. (ii) The amount of
gD
/
virus required to induce apoptosis was
significantly higher than that required to induce apoptosis by
gD
/+ virus.
|
Fate of gD
/
virus.
gD
/
viruses
have been shown to be able to attach to cell surfaces as a consequence
of the interaction of gB and gC with cell surface receptors but to be
unable to productively infect cells (24). The rationale of
this experiment was based on studies done some time ago showing that
whereas cells expressing gD block productive entry of wild-type virus,
virus particles are internalized in vesicles likely of endosomal origin
and degraded (9). To ascertain the fate of
gD
/
virus, SK-N-SH cells were exposed to 100 PFU
equivalents per cell and incubated for time intervals ranging from 30 min to 2 h. They were then harvested, fixed, sectioned, and
stained for electron microscopy as described in Materials and Methods.
The results shown in Fig. 4 were as
follows: (i) Virus particles attached to the cell surface (Fig. 4a to
d) were readily seen in section of cells harvested at 30 min to 2 h after exposure to virus. (ii) Internalized virus was seen only in
cells harvested 30 min after exposure to virus. In all instances (Fig.
4d to g), the virus was present in cytoplasmic vesicles and appeared to
be undergoing degradation. As shown below, cells exposed to
gD
/
virus do not express
genes, as evidenced by the
absence of ICP0.
|
/
virus is internalized in cells exposed to it.
gJ does not accumulate in cells infected with gD
/+
virus.
In principle, to attribute a function to a gene that has
been deleted, it is necessary to restore the gene and recover the wild-type phenotype. The failure of self-rescuants (Fig. 3) to induce
fragmentation of DNA is only partially convincing evidence since the
DNA fragment contained in the VD60 cells extended 3' and 5' beyond the
domain of the gD gene. The immediate environment of the gD gene
contains the genes encoding gJ (US5) and gI
(US7). To determine if these genes are expressed, SK-N-SH
cells were mock infected or exposed to 10 PFU of wild-type virus or
gD
/+ or gD+/+ rescuants per cell. The cells
were harvested at 18 h after infection, solubilized, subjected to
electrophoresis in denaturing gels, and reacted with a monoclonal
antibody to US7 (gI) (Fig.
5A) or polyclonal antibody to
US5 (Fig. 5B). The results were as follows: (i) the
electrophoretic mobility of gI expressed by P6 (gD
/+)
stock could not be differentiated from that of wild-type or rescuant
viruses, and (ii) gJ was not detected in cells infected with P6
(gD
/+) or P10 (gD
/+) stocks but was readily
detectable in cells infected with wild-type virus or self-rescuants
(Fig. 5B). The failure to detect gJ was reproducible in several
experiments. We conclude from this experiment that the
gD
/+ stocks contain an impaired gJ gene.
|
DNA fragmentation associated with apoptosis is blocked by trans
complementation of gD
/
.
The experiments described
above suggested that phenotypes of gD
/
and
gD
/+ viruses analyzed in these studies could be due to
either gD or gJ. The objective of this series of experiments was to
determine whether gJ or gD delivered in trans could block
the DNA fragmentation induced by gD
/+ or
gD
/
viruses. Two series of experiments were done. In
the first, we cloned gD, gJ, and gB driven by the immediate-early HCMV
promoter. Figure 6 shows that gD, gJ, and
gB were readily expressed in cells exposed to baculoviruses carrying
the corresponding gene and treated with sodium butyrate. The positive
control consisted of lysates of SK-N-SH cells exposed to HSV-1(F).
Although in this experiment the protein accumulation was measured
24 h after exposure to baculoviruses (Fig. 6A, C, and D), the
product of the gene carried by baculoviruses could be detected much
earlier. As shown in Fig. 6B, gD was readily detected as early as
4 h after exposure of cells to the recombinant baculovirus
carrying the gD gene.
|
/
or gD
/+ viruses. In the experiment illustrated in Fig.
7A, replicate subconfluent cultures of
SK-N-SH cells were mock infected, exposed to 10 PFU of recombinant
baculovirus per cell as indicated or to 100 PFU of Bac-XylE per cell,
or doubly infected with 10 PFU of recombinant baculovirus and either
100 PFU equivalents of gD
/
or 10 PFU of
gD
/+ mutant virus per cell. In the experiment illustrated
in Fig. 7B, replicate cultures of SK-N-SH cells were exposed to 18 PFU of recombinant baculovirus expressing gB per cell or exposed to both 18 PFU or baculovirus and either 100 PFU of gD
/
or 10 PFU
of gD
/+ virus per cell. The cells were harvested 24 h after exposure to virus and processed as described in Materials and
Methods. The results were as follows: None of the recombinant
baculoviruses induced DNA fragmentation by themselves (Fig. 7A, lanes 2 to 5; Fig. 7B, lane 2). gJ or gD blocked DNA fragmentation induced by gD
/
(Fig. 7A, lanes 7 and 8) or gD
/+
(Fig. 7A, lanes 12 and 13). None of the other recombinant baculovirus were able to block DNA fragmentation induced by the gD
/
or gD
/+ viruses.
|
Recombinant baculoviruses expressing gD or gJ do not block the
expression of recombinant viruses under the conditions tested.
The
objectives of the experiment described below were twofold: (i) to
determine whether simultaneous exposure of cells to gD
/
virus and baculovirus expressing gD or gJ altered the ability of
gD
/
virus to infect cells and express its genes; and
(ii) to determine whether expression of gD or gJ altered the capacity
of gD
/+ virus to express its genes since this virus was
expected to be able to attach, enter cells, and initiate productive
infection. SK-N-SH cells grown in microwells were infected with either
100 PFU equivalents of gD
/
or 10 PFU of
gD
/+ per cell singly or in combination with 10 PFU of
baculovirus expressing gD, gJ, or ICP22. The cells were fixed and
reacted with monoclonal antibody to ICP0. The digitized images
collected with the aid of a Zeiss confocal microscope are shown in Fig. 8. As expected, cells infected with
gD
/
virus singly or in combination with a recombinant
baculovirus failed to express ICP0. In contrast, the expression of ICP0
in cells infected with the gD
/+ mutant and either gD or
gJ could not be differentiated from that seen in cells infected solely
with the gD
/+ mutant.
|
gD and gJ do not block fragmentation of DNA induced by anti-Fas
antibody or TNF-
.
Earlier studies have shown that HSV-1 blocks
apoptosis induced by a number of stimuli, including anti-Fas antibody
and TNF-
(16, 21, 22, 34). Jerome at al. (21)
published evidence that mutants lacking the US5 encoding gJ
failed to suppress apoptosis induced by anti-Fas antibody. In light of
the results presented in this report, it was of interest to determine
whether either gJ or gD by itself and in the absence of other HSV
proteins could block DNA fragmentation induced by TNF-
or anti-Fas
antibody. To this end, SK-N-SH cells were mock infected or exposed to
10 PFU of HSV-1(F) or 10 PFU of baculovirus expressing gD or gJ per cell. Replicate cultures were exposed to TNF-
(10 µg/ml) at 2 h after infection or to anti-Fas antibody at 6 h after infection. The cells were harvested 18 h after infection and processed as described in Materials and Methods. The results were as follows: (i)
Degradation of DNA was not apparent in mock-infected cells (Fig. 9,
lane 1), cells infected with HSV-1(F)
(lane 4), or cells infected with baculoviruses expressing gD and gJ
(lanes 7 and 10, respectively). (ii) TNF-
or anti-Fas antibody
induced degradation of DNA (lanes 2 and 3), and this effect was not
suppressed by gD (lanes 8 and 9) or gJ (lanes 11 and 12). We conclude
that expression of these genes by themselves is not sufficient to block
apoptosis induced by TNF-
or anti-Fas antibody.
|
| |
DISCUSSION |
|---|
|
|
|---|
The life cycle of resting or dividing cells is tightly regulated. Cells whose genomes are damaged or which fail to meet parameters measured at specific checkpoints are induced to undergo a sequence of events resulting in programmed cell death. Viruses both damage and perturb cellular regulatory cascades, and these events in themselves are sufficient to induce programmed cell death. In some instances, the induction of programmed cell death serves as the preferred environment for viral replication (31). Many viruses, however, block programmed cell death as inimical to viral replication. HSV-1 is an example of a virus that both perturbs the cell and effectively blocks the cell from responding not only to the perturbations induced by the virus but also to the induction of an apoptotic cascade by exogenous agents (3, 16, 17, 23).
This report focused on very early events in the interaction of HSV-1 with its host cell. Our results indicate the following.
(i) gD
/+ stocks used in these studies lack intact genes
encoding gD and gJ. Since these stocks were used to produce
gD
/
virus in cells that do not carry HSV-1 DNA
sequences, the gD
/
mutants also lack both genes.
(ii) Both gD
/
and gD
/+ mutants induce
apoptosis in SK-N-SH cells, as shown by binding of annexin V to cell
surfaces and degradation of the DNA. Annexin V binding was detected as
early as 8 h after exposure of cells to the virus. The two virus
stocks differ, however, in two respects. First, gD
/+
stocks infect and replicate in cells that do not carry HSV-1 DNA
sequences, whereas gD
/
stocks do not replicate or
express de novo viral genes in either cells that carry HSV-1 DNA
sequences or those that do not. We have, however, shown that
gD
/
virus particles were internalized and contained in
vesicles and that they appeared to undergo degradation. These were
detected at 30 min after exposure of cells to the virus but not at
1 h after exposure. The second major difference is that we
estimate that higher multiplicities of infection are necessary to
induce apoptosis with gD
/
virus than with
gD
/+ mutants.
(iii) Degradation of cellular DNA characteristic of programmed cell
death was blocked in cells exposed to baculovirus expressing gD or gJ
and then infected with gD
/
or gD
/+ virus
stocks. The genes expressed by baculovirus vectors were driven by the
HCMV immediate-early promoter, and gene products were detected as early
as 4 h after exposure of cells to recombinant baculoviruses. This
is the first evidence (i) that gD or gJ can block apoptosis and (ii)
that either gene delivered in trans can block programmed
cell death induced by the same null mutant.
(iv) A virus lacking gJ was previously shown to be unable to block apoptosis induced by an exogenous agent, antibody to Fas (21). We show that under the conditions tested in the present study, gJ or gD was not sufficient to block fragmentation of DNA induced by anti-Fas antibody.
Three key issues have arisen in the course of this study: (i) how
gD
/
virus induces apoptosis, (ii) how
gD
/+ induces apoptosis in light of the evidence that it
causes a productive infection resulting in gD
/
progeny,
and (iii) the negative regulation of HSV-induced apoptosis exerted
independently by gD and gJ. We consider each of these issues separately.
(i) This study stemmed from the observation that tsB7 at the
nonpermissive temperature induces the apoptotic cascade in the absence
of de novo protein synthesis (16). The two mutually nonexclusive hypotheses that could explain that observation are that in
the course of viral replicative cycle one or more viral functions block
programmed cell death induced by the attachment of the virus to the
cell surface or due to the release of a virion protein into the newly
infected cell. The studies with gD
/
virus recapitulate
this conclusion. Although gD
/
virus is known to attach
to the cell surface and could potentially activate a stress response,
we have also shown that the virus is taken up and degraded in vesicles
likely to be of endosomal origin.
(ii) The available data do not exclude the possibility that the
interaction of HSV with the cell surface induces a stress response that
leads to apoptosis in the absence of counteracting viral functions
expressed later in infection. Of the various factors that come into
play, at least two can be excluded a priori. First, apoptosis was
induced irrespective of the presence of gD in the envelope of the virus
(gD
/
versus gD
/+); second, the absence of
gJ may also not be a factor since in the study of Jerome et al.
(21), gJ
virus by itself did not induce the
apoptotic cascade.
(iii) The available data also do not exclude the hypothesis that
apoptosis is triggered by a factor introduced into cells after
infection. The property shared by gD
/
and
gD
/+ viruses relevant to apoptosis does include
introduction of virion proteins into the cell. For gD
/+
virus, this would constitute the normal sequence of events leading to
productive infection. In the case of gD
/
virus, the
putative factor responsible for the induction of apoptosis could escape
degradation and be released from the endosomic compartment into the
infected cell. Since it is likely that only a small amount of this
factor would be introduced into the cell by this pathway, it could
account for the finding that gD
/
virus requires high
PFU equivalents to induce apotosis relative to the gD
/+
virus stock. We further note that entry of gD
/
virus
likely in the endocytic-lysosomal compartment may by itself represent a
stimulus to apoptosis, as activation of the lysosomal compartment has
been shown to induce apoptosis (30).
(iv) gD
/+ virus is the only HSV mutant found to date to
induced classical apoptosis and at the same time produce progeny
(gD
/
virus), presumably by expressing all genes other
than those that that have been specifically deleted. The self-rescuants
reported in this study provide evidence that no genes other than gD and gJ relevant to apoptosis are absent from the gD
/+ mutants.
(v) Inasmuch as apoptosis is not caused by the absence of gJ
(21), the property shared by the gD
/
and
gD
/+ viruses that could trigger apoptosis is the absence
of the gene encoding gD and not the absence of gD in the envelope of
the virus to which the cells were exposed. It follows therefore that
function of gD and gJ required to block apoptosis is expressed by the
proteins made de novo after infection.
(vi) There are at least three mechanisms by which the gD could block
apoptosis. The first and least likely involves the reported interaction
of gD with HveA, a member of the family of TNF receptors (28). HveA in turn interacts with LIGHT, a member of TNF
superfamily shown to mediate apoptosis via its interaction with
lymphotoxyn-
receptor (32). If gD were to block apoptosis
by this pathway, HveA presumably would induce apotosis in the absence
of gD. However, HveA is narrowly distributed in human tissues and has
been reported not to play a role in LIGHT-mediated apoptosis (28,
32).
The second mechanism would involve interaction of gD with nectins, members of the immunoglobulin superfamily that in uninfected cells function as intercelluar adhesion molecules (12, 19, 27, 36). In contrast to HveA, the nectins are broadly distributed in human cell lines and in human tissues. It is conceivable that in the absence of the gD ligand, disruption of intercellular adhesion by viral gene products during the course of the replicative cycle induces a stress that is remedied either by gD or gJ.
The third potential mechanism may involve interaction of gD, modified
by addition of mannose-phosphate with one of the two mannose-phosphate
receptors. It has been reported that during productive infection, a
small amount of gD becomes phosphorylated by addition of
mannose-6-phosphate residues, (6). At the time when this
interaction was described, the thought was that the mannose-6-phosphate
receptors could act as receptors for virus entry or could sort some of
the gD made during infection, modified by addition of phosphate
residues (6, 7). The possibility exists, however, that the
mannose-6-phosphate receptor interacts with mannose-6-phosphate-gD to
block apoptosis rather than to enable virus entry into cells. This
latter mechanism may be relevant to the gD-mediated block to apoptosis
induced by the gD
/
virus stock, which appears to be
taken up in a compartment likely of endocytic origin.
(iv) gJ is dispensable for viral replication at least in cultured
cells, and its function is not known. No cellular ligands have been
reported. The antiapoptotic stimulus mediated by gJ may differ
substantially from that induced by gD. HSV-1 lacking the gJ gene was
reported to be unable to block apoptosis induced by anti-Fas antibody,
suggesting that gJ plays an essential role in this process
(20). Our results indicate that gJ by itself is not able to
block apoptosis induced by an exogenous pathway such as Fas ligand but
can block apoptosis induced by either gD
/
or
gD
/+ viruses. The conclusion to be derived from these
data is that gJ acts at a signal transduction or post-signal
transduction stage, that it is sufficient to block the apoptotic
cascade in the case of gD
/
or gD
/+
viruses, but that it is not sufficient to block apoptosis by Fas
ligands under the conditions tested. At least in the case of
gD
/
virus, its function is independent from that of gD.
In essence, the results described in this report have shown (i) that viruses impaired in gD and gJ genes can induce programmed cell death and (ii) that in the case of viruses lacking both the gene and the glycoprotein it encodes, apoptosis results in the absence of de novo viral protein synthesis. The association of the missing function with apoptosis is clearly and unambiguously supported by the observation that administration of genes encoding the missing functions in trans blocked apoptosis and in essence reconstructed the phenotype of the wild-type virus. Studies now in progress may shed light on both the mechanism by which the cells are induced to activate the apoptotic cascade and the mechanism by which this cascade is blocked. The findings presented in this report are novel; they reinforce the growing realization that cells can respond by activating an apoptotic cascade to the presence of an invading pathogen and that HSV-1 too has evolved multiple functions to block the cell from doing just that.
| |
ACKNOWLEDGMENTS |
|---|
We thank David Johnson and Patricia G. Spear for the
gD
viruses and cells expressing gD, and we thank Shu-Fen
Chou for electron microscopy.
Work done at the University of Chicago was aided by Public Health Service grants CA47451, CA71933, and CA78766 from the National Cancer Institute. Work done at the University of Bologna was supported by grants from Target Project in Biotechnology/CNR, Telethon grant A141, MURST 40%.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: The Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, 910 E. 58th St., Chicago, IL 60637. (773) 702-1898. Fax: (773) 702-1631. E-mail: bernard{at}cummings.uchicago.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ackermann, M.,
M. Sarmiento, and B. Roizman.
1985.
Application of antibody to synthetic peptides for the characterization of the intact and truncated 22 protein specified by herpes simplex virus 1 and the R325 22 deletion mutant.
J. Virol.
56:207-215 |
| 2. |
Aubert, M., and J. A. Blaho.
1999.
The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells.
J. Virol.
73:2803-2813 |
| 3. |
Aubert, M.,
J. O'Toole, and J. A. Blaho.
1999.
Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1.
J. Virol.
73:10359-10370 |
| 4. |
Batterson, W.,
D. Furlong, and B. Roizman.
1983.
Molecular genetics of herpes simplex virus. VIII. Further characterization of a temperature-sensitive mutant defective in release of viral DNA and in other stages of viral reproductive cycle.
J. Virol.
45:397-407 |
| 5. |
Batterson, W., and B. Roizman.
1983.
Characterization of the herpes simplex virion-associated factor responsible for the induction of genes.
J. Virol.
46:371-377 |
| 6. | Brunetti, C. R., R. L. Burke, B. Hoflack, T. Ludwig, K.S. Dingwell, and D.C. Johnson. 1995. Role of mannose-6-phosphate receptors in herpes simplex virus entry into cells and cell-to-cell transmission. J. Virol. 69:3517-3528[Abstract]. |
| 7. |
Brunetti, C. R.,
K. S. Dingwell,
C. Wale,
F. L. Graham, and D. C. Johnson.
1998.
Herpes simplex virus gD and virions accumulate in endosomes by mannose 6-phosphate-dependent and -independent mechanisms.
J. Virol.
72:3330-3339 |
| 8. |
Cai, W.,
B. Gu, and S. Person.
1988.
Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion.
J. Virol.
62:2596-2604 |
| 9. |
Campadelli-Fiume, G.,
M. Arsenakis,
F. Farabegoli, and B. Roizman.
1988.
Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in the degradation of the virus.
J. Virol.
62:159-167 |
| 10. | Campadelli-Fiume, G., F. Cocchi, L. Menotti, and M. Lopez. 2000. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev. Med. Virol. 10:305-319[CrossRef][Medline]. |
| 11. |
Chang, Y. E.,
L. Menotti,
F. Filatov,
G. Campadelli-Fiume, and B. Roizman.
1998.
UL27.5 is a novel 2 gene antisense to the herpes simplex virus 1 gene encoding glycoprotein B.
J. Virol.
72:6056-6064 |
| 12. |
Cocchi, F.,
L. Menotti,
P. Mirandola,
M. Lopez, and G. Campadelli-Fiume.
1998.
The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells.
J. Virol.
72:9992-10002 |
| 13. | DeLuca, N. A., A. McCarth, and P. A. Shaffer. 1985. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 58:558-570. |
| 14. |
Ejercito, P. M.,
E. D. Kieff, and B. Roizman.
1968.
Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.
J. Gen. Virol.
2:357-364 |
| 15. |
Forrester, A.,
H. Farrell,
G. Wilkinson,
J. Kaye,
N. Davis Poynter, and T. Minson.
1992.
Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted.
J. Virol.
66:341-348 |
| 16. |
Galvan, V., and B. Roizman.
1998.
Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner.
Proc. Natl. Acad. Sci. USA
95:3931-3936 |
| 17. |
Galvan, V.,
R. Brandimarti, and B. Roizman.
1999.
Herpes simplex virus 1 blocks caspase-3-independent and caspase-dependent pathways to cell death.
J. Virol.
73:3219-3226 |
| 18. | Galvan, V., R. Brandimarti, J. Munger, and B. Roizman. 2000. Bcl-2 blocks a caspase-dependent pathway of apoptosis activated by herpes simplex virus 1 infection in HEp-2 cells. J. Virol. 74:1913-1938. |
| 19. |
Geraghty, R. J.,
C. Krummenacher,
G. M. Cohen,
R. J. Eisenberg, and P. G. Spear.
1998.
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor.
Science
280:1618-1620 |
| 20. |
Herold, B. C.,
D. WuDunn,
N. Soltys, and P. G. Spear.
1991.
Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity.
J. Virol.
65:1090-1098 |
| 21. |
Jerome, K. R.,
R. Fox,
Z. Chen,
A. E. Sears,
H.-E. Lee, and L. Corey.
1999.
Herpes simplex virus inhibits apoptosis through the action of two genes, US5 and US3.
J. Virol.
73:8950-8957 |
| 22. | Koyama, A. H., and Y. Miwa. 1997. Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. J. Virol. 71:2567-2571[Abstract]. |
| 23. |
Leopardi, R., and B. Roizman.
1996.
The herpes simplex virus 1 major regulatory protein ICP4 blocks apoptosis induced by the virus or by hypothermia.
Proc. Natl. Acad. Sci. USA
93:9583-9587 |
| 24. |
Leopardi, R.,
C. Van Sant, and B. Roizman.
1997.
The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus.
Proc. Natl. Acad. Sci. USA
94:7891-7896 |
| 25. |
Ligas, M. W., and D.C. Johnson.
1988.
A herpes simplex virus mutant in which glycoprotein D sequences are replaced by -galactosidase sequences binds to but is unable to penetrate into cells.
J. Virol.
62:1486-1494 |
| 26. |
Longnecker, R.,
S. Chatterjee,
R. J. Whitley, and B. Roizman.
1987.
Identification of a novel herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture.
Proc. Natl. Acad. Sci. USA
84:4303-4307 |
| 27. |
Lopez, M.,
M. Aoubala,
F. Jordier,
D. Isnardon,
S. Gomez, and P. Dubreuil.
1998.
The human poliovirus receptor related 2 protein is a new hematopoietic/endothelial homophilic adhesion molecule.
Blood
92:4602-4611 |
| 28. | Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436[CrossRef][Medline]. |
| 29. |
Ogle, W. O., and B. Roizman.
1999.
Functional anatomy of herpes simplex virus 1 overlapping genes encoding infected-cell protein 22 and US1.5 protein.
J. Virol.
73:4305-4315 |
| 30. |
Okaka, C., and T. Mizuochi.
1999.
Role of macrophage lysosomal enzymes in the degradation of nucleosomes of apoptotic cells.
J. Immunol.
163:5346-5352 |
| 31. | Ran, Z., B. Rayet, J. Rommelaere, and S. Faisst. 1999. Parvovirus H-1-induced cell death: influence of intracellular NAD consumption on the regulation of necrosis and apoptosis. Virus Res. 65:161-174[CrossRef][Medline]. |
| 32. |
Rooney, I. A.,
K. D. Butrovich,
A. A. Glass,
S. Borboroglu,
C. A. Benedict,
J. C. Whitbeck,
G. H. Cohen,
R. J. Eisenberg, and C. F. Ware.
2000.
The lymphotoxin receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells.
J. Biol. Chem.
275:14307-14315 |
| 33. |
Roop, C.,
L. Hutchinson, and D. C. Johnson.
1993.
A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H.
J. Virol.
67:2285-2297 |
| 34. | Sieg, S., Z. Yildirim, D. Smith, N. Kayagaki, H. Yagita, Y. Huang, and D. Kaplan. 1996. Herpes simplex virus type 2 inhibition of Fas ligand expression. J. Virol. 70:8747-8751[Abstract]. |
| 35. | Spear, P. G. 1993. Entry of alphaherpesviruses into cells. Semin. Virol. 4:167-180. |
| 36. |
Takahashi, K.,
H. Nakanishi,
M. Miyahara,
K. Mandai,
K. Satoh,
A. Satoh,
H. Nishioka,
J. Aoki,
A. Nomoto,
A. Mizoguchi, and Y. Takai.
1999.
Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with afadin, a PDZ domain-containing protein.
J. Cell Biol.
145:539-549 |
| 37. | Ward, P. L., W. O. Ogle, and B. Roizman. 1996. Assemblons: nuclear structures defined by aggregation of immature capsids and some tegument proteins of herpes simplex virus 1. J. Virol. 70:4623-4631[Abstract]. |
| 38. |
WuDunn, D. W., and P. G. Spear.
1989.
Initial interaction of herpes simplex virus with cells is binding to heparin sulfate.
J. Virol.
63:52-58 |
| 39. |
Zhou, G., and B. Roizman.
2000.
Wild-type herpes simplex virus 1 blocks programmed cell death and release of cytochrome c but not the translocation of mitochondrial apoptosis-inducing factor to the nuclei of human embryonic fibroblasts.
J. Virol.
74:9048-9053 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»